Esperion Therapeutics, Inc. - COM (ESPR)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
137M
Holdings value Q2 2024
$304M
Value change Q2 2024
+$17.7M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
172
Number of buys Q2 2024
19
Number of sells Q2 2024
-12
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 4.49M $7.42M -$1.11M $1.65 43
2024 Q2 137M $304M +$17.7M $2.22 177
2024 Q1 125M $336M +$141M $2.68 148
2023 Q4 71.6M $214M -$13.2M $2.99 128
2023 Q3 77.2M $75.7M -$1.73M $0.98 123
2023 Q2 74.3M $103M -$10.5M $1.39 124
2023 Q1 80.9M $129M -$22.1M $1.59 165
2022 Q4 73.4M $458M +$39.2M $6.23 168
2022 Q3 62.4M $418M +$53.3M $6.70 144
2022 Q2 55.4M $352M +$25.3M $6.36 131
2022 Q1 51.7M $240M -$10.7M $4.64 124
2021 Q4 53.4M $267M +$97.3M $5.00 119
2021 Q3 24.6M $296M -$61.5M $12.05 134
2021 Q2 28.1M $595M -$18.9M $21.15 139
2021 Q1 28.5M $799M -$64.5M $28.05 152
2020 Q4 30.9M $803M -$34.2M $26.00 152
2020 Q3 31.6M $1.18B -$28.8M $37.17 165
2020 Q2 32M $1.64B +$124M $51.31 179
2020 Q1 29.6M $916M +$54M $31.53 157
2019 Q4 27.8M $1.62B +$45.9M $59.63 171
2019 Q3 27M $991M -$72.2M $36.66 146
2019 Q2 28.4M $1.32B +$217M $46.52 166
2019 Q1 27.6M $1.11B +$27M $40.15 161
2018 Q4 26.8M $1.23B -$65.8M $46.00 155
2018 Q3 28.3M $1.25B -$107M $44.37 155
2018 Q2 30.8M $1.21B +$133M $39.19 155
2018 Q1 26.5M $1.91B +$178M $72.33 186
2017 Q4 24M $1.58B +$28.5M $65.84 165
2017 Q3 24.1M $1.21B +$162M $50.12 148
2017 Q2 20.7M $958M +$140M $46.28 127
2017 Q1 18M $635M +$202M $35.31 116
2016 Q4 14.8M $185M +$1.08M $12.52 95
2016 Q3 14.4M $199M -$168K $13.85 99
2016 Q2 14.5M $144M -$26.8M $9.88 96
2016 Q1 15.6M $264M -$13.1M $16.91 103
2015 Q4 16.4M $366M -$11.9M $22.26 113
2015 Q3 16.6M $392M -$216M $23.59 124
2015 Q2 15.3M $1.25B +$185M $81.76 149
2015 Q1 12.8M $1.19B +$472M $92.60 142
2014 Q4 7.76M $314M +$168M $40.44 81
2014 Q3 3.5M $85.6M +$3.07M $24.46 49
2014 Q2 5.56M $88M +$33.7M $15.84 43
2014 Q1 3.43M $51.9M +$1M $15.12 39